Ghassan Abou-Alfa
@GABOUALFA
Followers
5K
Following
4K
Media
715
Statuses
3K
@MSKCancerCenter Medical Oncologist, liver, cholangiocarcinoma, gallbladder, biliary cancer specialist. Global healthcare specialist. Patients’ advocate.
New York, USA
Joined November 2014
What a delight seeing excellence being celebrated. Congratulations @EileenMOReilly for the @tcddublin #Burkitt medal. Your smile speaks millions of miles of beyond impressive #PancreaticCancer research and medical care from @tcddublin to @MSKCancerCenter @MSK_DeptOfMed
26
25
231
Thanks @LBpresidency @Najib_Mikati for bestowing @GABOUALFA Order of Honor of #Lebanon. Great honor to continue work @MSKCancerCenter @MSK_DeptOfMed for improving of #cancer #care for all. Congrats @AUB_Lebanon for help start global efforts. Thanks @FordhamLawNYC for enhancing
36
13
227
Great news for all patients with biliary tumors! Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer | NEJM Evidence
2
72
175
Congratulations @EileenMOReilly for the @MJHLifeSciences #giantsofcancer #2023 #gastrointestinalcancer . @MSKCancerCenter @MSK_DeptOfMed and we are all proud of you! Congratulations
13
18
175
After 82 years of excellence life span, Prof #Burkitt is reassured of his continued legacy . Congratulations @EileenMOReilly
15
14
167
Thank you @AUB_Lebanon @DrFadloKhuri for your peaceful support of #LebanonProtests this genuine effort for #Lebanon
2
32
161
Eileen O’Reily named the incumbent of the Winthrop Rockefeller Chair of Meidcal Oncology @sloan_kettering . This is well deserved! Congratulations Eileen!.
12
21
153
Delighted and honored! @gaboualfa awarded Adjunct Professorship @tcddublin @TrinityMedNews. Happy to see extended venue for @MSKCancerCenter @MSK_DeptOfMed work on #medicaldiplomacy
14
6
133
#HIMALAYA is positive! Congratulations to all patients. @sloan_kettering @GABOUALFA honored to have led #HIMALAYA globally!.
11
28
127
What a beautiful morning welcoming @DrFadloKhuri by @EileenMOReilly and @GABOUALFA at @sloan_kettering. All delighted to continue celebrate and enhance the @AUB_Lebanon @sloan_kettering strong relationship and collaboration
2
6
118
Now with FDA approval, this is the final Efficacy of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation via @JAMAOnc part of @JAMANetwork. Congratulations to all!.
2
31
94
Congratulations @EileenMOReilly on new @sloan_kettering chairmanship of the Human Research Protection Program (HRPP) IRB Head, and thanks Rober Wilson on an amazing job over the years. Thank you both on an examplary transition of leadership.
1
11
75
Just in @GABOUALFA @sloan_kettering reports #ivosidenib @AgiosPharma improved PFS HR 0.37 and OS HR 0.46 versus placebo . Great news for #IDH mutant #Cholangiocarcinoma patients.
5
16
71
Congratulations @EileenMOReilly and thank you @tcddublin.Sir Denis #Burkitt is sure proud of your incredible achievements for all #patients
5
4
66
Shocking and intriguing #LEAP002 study of #pembrolizumab plus #lenvatinib is negative. And proved #lenvatinib to be a great #HCC therapy
4
10
68
Congratulations to all patient on a new therapy for #cholangiocarcinoma, and thanks @AgiosPharma for acting on @GABOUALFA recommendation back in 2015 #ivosidenib #Phase3 is positive!
4
18
64
On behalf of all co-authors @GABOUALFA looking forward to present the #HIMALAYA study for #HCC at #GI22 @ASCO on Friday. After showing #MOA and data, let’s reflect further on the single dose of #tremelimumab in combination with #durvalumab meaning later that day with @DrNeilLove.
1
7
65
A @sloan_kettering collaborative effort end to end with President Craig Thompson defining #CTLA4, @CancerCureDoc receiving @NobelPrize for defining anti-CTLA4 therapy, and now @GABOUALFA humbled and honored to present the positive outcome of the #HIMALAYA study in 2 hours #GI22
3
3
63
Congratulations on a great effort showing equivalency of nivolumab and sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
4
15
64
FGFR2 fusion/rearrangement cholangiocarcinoma patients hopefully will have a treatment option soon. Just in! Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
1
25
63
Great honor and pleasure for @GABOUALFA @sloan_kettering as new member @ASCO International Affairs Committee along with Dr. Yeon Hee Park (S. Korea), Dr. Kazuhiro Yoshida (Japan), Dr. Mary McCormack (United Kingdom), Dr. Matias Chacon (Argentina) and Dr @drsmgueye (Senegal).
7
5
64
Thank you @tcddublin Provost @LindaDoyle for welcoming @MSKCancerCenter @EileenMOReilly @GABOUALFA and @CancerInstIRE co-director Maeve Lowery at your home and discuss #healthdiplomacy and more!
3
5
62
Great news to all our dear patients! @sloan_kettering @GABOUALFA honored to have led this global effort with @Incyte and all great colleagues!.
#Breaking: The @US_FDA has approved the first targeted treatment for adults with previously treated, unresectable locally advanced or metastatic #cholangiocarcinoma.
1
9
61
2
6
61
Great news to all patients. @GABOUALFA @sloan_kettering honored to have led and collaborated on the effort of @ExelixisInc Announces U.S. FDA Approval of CABOMETYX® (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma | Business Wire
4
21
59
Biking back home from @FordhamLawNYC at 10pm after 4 hours gruelling exam in #property. Thanks @MSKCancerCenter @MSK_DeptOfMed for the opportunity!
2
0
63
Roche - Roche presents pivotal data demonstrating Tecentriq in combination with Avastin improves overall survival in people with the most common form of liver cancer
2
12
60
KRAS the ultimate target in #PancreaticCancer by @MSKCancerCenter @MSK_DeptOfMed @EileenMOReilly at #ESMO22 in #Paris
0
12
61
Greatest pride for @sloan_kettering @EileenMOReilly chosen @tcddublin graduate to congratulate @tcddublin @stjamesdublin on the establishment of @CancerInstIRE
4
8
61
Congratulations to all @AUB_Lebanon physicians for advanced training graduation. Thoughtful and invigorating speech @DrFadloKhuri in difficult times!
2
2
59
Solidarity and support of @sloan_kettering to @AUB_Lebanon in the aftermath of the #BeirutExplosion. Thank you all for your support.
2
14
58
Thanks @FordhamNYC @FordhamLawNYC for @GABOUALFA first #lawyer headshot, and thanks @sloan_kettering for envisioning what a #JD can add to our dear institution. Looking forward for further bridging of the two institutions for what is best for #humanity. Thanks @FordhamEvening
4
3
57
Stay tuned! Tomorrow Monday 430 pm CST 1030 am EDST @GABOUALFA @sloan_kettering present positive results of @AgiosPharma #ClarIDHy phase III study in #Cholangiocarcinoma at @myESMO in #Barcelona
2
16
57
Happy to see an @FDAOncology approved #pemigatinib second line therapy for #cholangiocarcinoma patients with #FGFR2 fusion or other rearrangements. Live .@TheLynxGroup @GABOUALFA all about #cholangiocarcinoma
2
13
57
Congrats @AUB_Lebanon on impeccable audit of @MSKCancerCenter @AUBMC_Official joint tissue bank. Amazing joint effort of @MSKCancerCenter @EileenMOReilly #IRB @Abualfaa @FuadZiyadeh @AUB_IRB @MarkRobsonMD and many other colleagues since 2013. Thanks Ayman Tawil and Miriam Kanso!
3
7
58
Thank you @AUBAlumni all members for your trust in @GABOUALFA as a Trustee on the @AUB_Lebanon Board of Trustees. It is a great honor and pride to give back to @AUB_Lebanon.
6
2
55
Great news for #PancreaticCancer patients and science! Personalized neoantigen tumor vaccine and anti PD-L1 study is now open @sloan_kettering . Thanks and congrats @TheVinodLab @EileenMOReilly.
1
12
53
The pride of @MSKCancerCenter @AUB_Lebanon strong many decades relationship is celebrated with superb MD students and children of @AUBAlumni. Congratulations Nour, Tamara, and Nadine. @MSK_DeptOfMed @TeamOvary_MSK @GABOUALFA are delighted to welcome you!
1
3
53
Busy week for hepatobiliary cancers: Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
1
22
51
On the eve of #Lebanon first centennial @AUB_Lebanon was already there and still is! Hand in hand in the good days and the bad days.
0
7
48
Yes @MSKCancerCenter @MSK_DeptOfMed @GABOUALFA honored and delighted to hear of his nomination for @AORTIC_AFRICA VP for North America. Great slate of many great candidates. Thanks for you vote and support.
3
3
47
0
3
44
Very early good morning from @sloan_kettering . The start of another day of #cancer #PatientCare globally
0
0
46
Final firm proof of #pemigatinib open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202☆ - ESMO Open Great international and successfully led team work of @MSKCancerCenter @MSK_DeptOfMed @GABOUALFA @ArndtVogel @HollebecqueA ++.
4
16
44
Great start @AUB_Lebanon on prompt #COVID19 #vaccine #campaign. Thanks to all @AUBMC_Official #HealthcareHeroes
0
0
44
Congrats and thanks! Always a delight to have more options! Pembrolizumab + gemcitabine and cisplatin v. gemcitabine and cisplatin alone for patients with BTC (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
1
6
43
God bless your soul Dear Dr Arti Hurria and thanks for great work with @WTapMD. Thank you @MSK_GeriOnc @VParoder for an incredible @sloan_kettering #GlobalGIOncologyFellowConference on #geriatrics GI Oncolgoy. See you all December 8 with Dr David Kelsen. And Happy #Thanksgiving
2
9
44
Great honor @GABOUALFA @sloan_kettering chair of #Hepatobiliary @theNCI #taskforce under the direction of @NCIDirector plus help and support of Wolf Lindwasser and team from 2013 to 2020! Thank you! Time to head to the exit door and open the opportunity for the next generation!
0
1
44
Thanks @sloan_kettering. Great honor indeed and delight to serve our institution from a new and novel perspective. Read all at
The doc that does it all! Thank you, @GABOUALFA for all you do @sloan_kettering and beyond! #backtoschool .
7
1
43
Thank you all for joining @sloan_kettering #GlobalGIFellows conference today. Thanks @ILSONDavid @BiachiTiago @VParoder for great discussion & congrats @YJanjigianMD for continued great work. Thanks @EileenMOReilly @SirohiBhawna James Harding and all for great input as always!
1
9
44
Superb one day @AUB_Lebanon. Thanks @DrFadloKhuri Raymond Sawaya @FuadZiyadeh @NagiSaghir @Abualfaa for a continued 17+ years @MSKCancerCenter @AUB_Lebanon interaction. It looks like yesterday for the back and forth @AUB_IRB @MSKCancerCenter @EileenMOReilly IRB visits.
0
3
42
0
3
40
2
6
41
The Observership Program the pride of @sloan_kettering at best! @Betzabe100 and @GABOUALFA made sure to cherish the opportunity and build a supper successful program of @incanMX @sloan_kettering with contributions form @DukeCancer @MayoCancerCare and more!
0
4
41
Overcoming #COVID19. Congratulations and thanks @sloan_kettering @MSKCME on holding a successful #mskHemeonccme with 100+ digital connects that would fill this conference room. Thanks for in-person attendees too! Thanks to @sloan_kettering SVP Digital Officer @ClausTorpJensen
4
2
39
0
3
39
Honored 4 appointment: Vice-Chair of @theNCI-sponsored @AMC_Studies #AIDS Malignancy Consortium Solid Tumor Working Group. Looking forward to continue @MSKCancerCenter @MSK_DeptOfMed 1decade+ collaborative work for a better understanding and Rx of #HCC in PLWHA in #US #Africa &🌍.
5
4
39
Meet #IMJUDO (#tremelimumab) @FDAOncology approved #trememlimuab part of #STRIDE (T300+D) for #HCC as per the positive outcome of the #HIMALAYA study. @MSKCancerCenter @MSK_DeptOfMed @GABOUALFA honored and delighted to have led and bring one more drug to dear patients with #HCC.
0
12
38
0
13
36
Congratulations @sloan_kettering @MSKCME @EileenMOReilly and team on an incredible #pancreascancersymposium happening as we speak!
0
6
39
And the noble spirited @EileenMOReilly thanking every member of @MSKCancerCenter @MSK_DeptOfMed @tcddublin for superb team work that led to today’s #Burkitt medal. Congratulations!
1
6
37
15 Years in the making and still going @MSKCancerCenter @AUB_Lebanon joint tissue bank. Non-stop monthly meeting with co-PI @MohamadJawadKh1 @GABOUALFA. Thank you Christine Monita Maya Miriam Dr Saheb and welcome Yasmina!
0
3
38
Years, not months. @MSKCancerCenter @MSK_DeptOfMed @GABOUALFA present collaborative efforts of Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable #HCC in @Annals_Oncology
0
9
38
Not to miss @EileenMOReilly discussing #PancreaticCancer @MSKCancerCenter @MSKCME . Superb as always! Thanks @ILSONDavid and Peter Hamlin!
1
6
37
Finally another drug for patients with with #cholangiocarcinoma this time with #mIDH1. Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in IDH1-Mutated Cholangiocarcinoma
0
11
38
FDA Approves New Immunotherapy Combination To Treat Advanced Liver Cancer Thanks @MSKCancerCenter @MSK_DeptOfMed for providing this superb environment to help provide better #therapy for all dear #patients #worldwide.
2
9
37
Superb opportunity to welcome @QUBCancerProf and @AlCRIproject Ciaran Briscoe to @MSKCancerCenter. Great delight for @MSK_DeptOfMed @LarryNortonMD @GABOUALFA @EileenMOReilly to discuss moving forward the global oncology medical diplomacy work started at @MSKCancerCenter
0
5
38
Great honor for @sloan_kettering and @GABOUALFA . Thank you @ASCO . It is all done for better patients’ care.
🚨 @ASCO highlights research by Drs. Motzer (@motzermd) and Abou-Alfa (@GABOUALFA) as a major advance in annual report on progress against cancer:
0
4
36
Merck and Eisai Provide Update on Phase 3 LEAP-002 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular Carcinoma did not meet primary OS -
2
22
36
In support of @AUB_Lebanon! #MD92 class @GABOUALFA @FaekJ @DrKayleClinic @mgfakih and many more colleagues connected today on @zoom_us from throughout the globe. Thank you all for caring for and supporting @AUB_Lebanon
3
4
36
Another super news! Congrats to dear patients snd superb team led by Lipika Goyal. FDA Approves Futibatinib for FGFR2+ Advanced Cholangiocarcinoma via @targetedonc.
0
12
35
Hello #WorldGI2021 #Barcelona from @sloan_kettering #NewYork. @EileenMOReilly with enlightening pearls of the POLAR study!
0
12
36
The famous annual #chicagodog @GreatDebatesCME #GDUGI23 Missing again @jordanberlin5 @JoshSmithMDPhD .
3
3
36
. @GABOUALFA honored and pleased to meet and congratulate @AUB_Lebanon Dr Ali Shamseddine on @AUBMC_Official team effort on short RT course followed by FOLFOX for recall cancer @ASCO #GI20
0
2
35
As we speak @MSKCancerCenter @MSK_DeptOfMed @debschrag presenting @ALLIANCE_org #PROSPECT @ASCO plenary session. Congratulations on positive outcome study and thank you for showing us what #perseverance leads to!
1
9
33
Congratulations @debschrag. Phenomenal superb work with a robust impact onto what is better for #humanity. We are all @MSKCancerCenter proud of you and thank you for leading @MSK_DeptOfMed as @MJHLifeSciences #giantsofcancer
1
3
34
Congratulations @oa_schultz, Dr Sarah Hwang, Dr Jasmit Heera, Dr Vladimir Falb, and Dr Anas Zaher on incredible work on your @MSK_DeptOfMed rotation @MSKCancerCenter. @GABOUALFA greatly honored for the opportunity to work with you all! Best of luck for your futures!
0
5
35
Big smiles for big work efforts @m_mutebi, @MSKCancerCenter @MSK_DeptOfMed @GABOUALFA and other colleagues, all happening at @AORTIC_AFRICA in #Senegal . Stay tuned!
1
3
35
Good early morning to all from @sloan_kettering . Wish a great evening to all dear colleagues in #Asia #Africa #Europe. See you tomorrow early morning for #APPLESTC2020 . Proud to see we have registrants from every continent already. Please register at
3
2
34
Few minutes before @FDAOncology approval of #atezobev for #HCC, @GABOUALFA broader delineation of #atezobev and #T300plusD on
1
6
34
What a better place for @MSKCancerCenter @MSK_DeptOfMed @GABOUALFA and @AORTIC_AFRICA @m_mutebi to meet but the @WhiteHouse during the @Cancer_Moonshot Africa meeting
1
1
31
Next stop #Barcelona. Join us #WCGI2023. @MSKCancerCenter @MSK_DeptOfMed @EileenMOReilly @GABOUALFA and colleagues waiting to welcome you!
1
4
31
Ongoing discussion among @MSKCancerCenter @MSK_DeptOfMed @GABOUALFA @ferguskeane2 @EmilyHarrold6, @tcddublin @CancerInstIRE Maeve Lowery @OanaDeac, @QUBelfast @QUBCancerProf and @ucddublin @EibhlinMulroe to better understand #cancer incidence #disparity in the island of #Ireland
1
6
33
Inaugural @MSKCancerCenter Law and Medicine Grand Rounds. Thank you all for attending. Thanks @FordhamLawNYC for another great collaboration!
0
4
32
1
3
33
Congrats Kenneth Yu @EileenMOReilly @MSK_DeptOfMed @MSKCancerCenter for Circulating tumor & invasive cell expression profiling predicts effective therapy in pancreatic cancer @GABOUALFA @AnnaVarghese4 @ImaneDika + other colleagues delighted to be part!.
0
12
30
Valuable time @GABOUALFA spent @AUB_Lebanon students trainees faculty and administrators. Thank you all for the great work in the most difficult of times and for your great belief in @AUB_Lebanon. Thank you @DrFadloKhuri for helping keep the ship afloat and still sailing!.
#AUBAlumniNews: AUB Trustee and alumnus Ghassan Abou-Alfa visited his alma mater recently to speak with President Fadlo Khuri and many colleagues and good friends about the extraordinary initiatives at AUB and AUBMC during these challenging times.
1
1
33
Congratulations #LSMO @infomedleb @ASCO on a great #BestofASCO still ongoing live! Virtuality at best! @AUB_Lebanon @sloan_kettering @EileenMOReilly @GABOUALFA #AliShamseddine @SallyTemraz @DrFadloKhuri @DrChoueiri @dmukherji and more colleagues from all over the world!
0
5
32
Thanks & congratulations @EileenMOReilly @ferguskeane2 Laura Tang Raazi Bajwa @VParoder for great #PancreaticCancer learning opportunity. @MSKCancerCenter @MSK_DeptOfMed @GABOUALFA honored and delighted to welcome you again on June 22 with @AndreaCercek on #ColonCancer in young
0
5
33
All @GABOUALFA @Twitter header photos are about #liver #globalhealth and more! This is #rapanui Easter Island @theeasterisland #volcano where Streptomyces hygroscopius was discovered by #Canada expedition Suren Segal in 1972, and where the name #rapamycin come from!
2
3
31
Congratulations to @ImaneDika for completing her #fellowship @sloan_kettering under #mentorship @GABOUALFA and joining #faculty @sloan_kettering
9
3
29